Why Greg Engle is Leaving Big Pharma for Medical Cannabis

Warning message

The subscription service is currently unavailable. Please try again later.

Written by Greg Engle

I have dedicated my entire career to the health care industry because it's important to me to spend my life doing something that helps people. Now, after more than 25 years, I have decided to leave behind the big pharma establishment in order to embark on a new journey on the cutting edge of health care, as the first CEO of Tilray, Canada's leading licensed producer of medical cannabis.

Here are the top five reasons why:

1. Patients deserve better. Last year, Canada made history when it became one of the first countries in the world to create a federally-sanctioned, commercial medical cannabis industry that treats medical cannabis more like medicine than contraband. The change in regulations sparked a much-needed, national dialogue about what we should expect of our healthcare system and the role that medical cannabis should play as a treatment option for patients in...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.huffingtonpost.ca/greg-engel/why-im-leaving-big-pharma_b_6838474.html